Alain D. Cappeluti
Directeur Général chez Noble Life Sciences, Inc.
Profil
Alain D.
Cappeluti is the founder and currently holds the position of Chairman & President at OTraces, Inc., which was founded in 2008.
He is also currently serving as President & Chief Executive Officer at Noble Life Sciences, Inc. and as a Director at CavitroniX Corp.
Mr. Cappeluti previously held the position of Chief Financial Officer & Director at NexImmune, Inc., Vice President-Finance at Human Genome Sciences, Inc., and Principal at BioReliance Corp.
From 2006 to 2008, he served as the Chief Financial Officer at Teva Biopharmaceuticals USA, Inc. Mr. Cappeluti completed his undergraduate degree at Old Dominion University in 1977.
Postes actifs de Alain D. Cappeluti
| Sociétés | Poste | Début |
|---|---|---|
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Directeur Général | - |
OTraces, Inc.
 OTraces, Inc. Medical/Nursing ServicesHealth Services OTraces, Inc. provides transformative oncology diagnostic systems and services to detect cancer. It has developed a protein-based method (proteomics) for detecting cancers with simple blood tests. It offers CDx instrument system, OTraces reagenat test kits, BC sera Dx test kit, PR sera Dx test kit, and Pipeline. The company was founded by Keith Lingerfelter and Alain Cappeluti in 2008 and is headquartered in Sykesville, MD. | Fondateur | 01/01/2008 |
CavitroniX Corp.
 CavitroniX Corp. Industrial MachineryProducer Manufacturing CavitroniX Corp. manufactures custom design and development of emulsion chambers for boilers, turbines and engines. It specializes in engineering, design, development, manufacturing and sale of water-in-fuel emulsification units. The company was founded by Charle P. Lickson, Charles Markert and Michael Noble in 2006 and is headquartered in Bristol, VA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Alain D. Cappeluti
| Sociétés | Poste | Fin |
|---|---|---|
| NEXIMMUNE, INC. | Directeur Financier/CFO | 09/01/2020 |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Directeur Financier/CFO | - |
BioReliance Corp.
 BioReliance Corp. Pharmaceuticals: MajorHealth Technology BioReliance Corp. provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies. It provides outsourced services to customers from most healthcare disciplines, including pharmaceutical, biopharmaceutical and chemical companies in the world. The firm also provides safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries. The company enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance was founded by Charles E. Bender in 1947 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Directeur Financier/CFO | - |
Formation de Alain D. Cappeluti
| Old Dominion University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEXIMMUNE, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
Noble Life Sciences, Inc.
Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Health Technology |
OTraces, Inc.
OTraces, Inc. Medical/Nursing ServicesHealth Services OTraces, Inc. provides transformative oncology diagnostic systems and services to detect cancer. It has developed a protein-based method (proteomics) for detecting cancers with simple blood tests. It offers CDx instrument system, OTraces reagenat test kits, BC sera Dx test kit, PR sera Dx test kit, and Pipeline. The company was founded by Keith Lingerfelter and Alain Cappeluti in 2008 and is headquartered in Sykesville, MD. | Health Services |
BioReliance Corp.
BioReliance Corp. Pharmaceuticals: MajorHealth Technology BioReliance Corp. provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies. It provides outsourced services to customers from most healthcare disciplines, including pharmaceutical, biopharmaceutical and chemical companies in the world. The firm also provides safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries. The company enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance was founded by Charles E. Bender in 1947 and is headquartered in Rockville, MD. | Health Technology |
CavitroniX Corp.
CavitroniX Corp. Industrial MachineryProducer Manufacturing CavitroniX Corp. manufactures custom design and development of emulsion chambers for boilers, turbines and engines. It specializes in engineering, design, development, manufacturing and sale of water-in-fuel emulsification units. The company was founded by Charle P. Lickson, Charles Markert and Michael Noble in 2006 and is headquartered in Bristol, VA. | Producer Manufacturing |
